您的位置: 首页 > 农业专利 > 详情页

Novel vaccine adjuvants based on targeting adjuvants to antibodies directly to antigen-presenting cells
专利权人:
BAYLOR RESEARCH INSTITUTE
发明人:
ZURAWSKI, GERARD,BANCHEREAU, JACQUES F.,FLAMAR, ANNE-LAURE,KANE, ROBERT R.
申请号:
TW101107940
公开号:
TW201247706A
申请日:
2012.03.08
申请国别(地区):
TW
年份:
2012
代理人:
摘要:
The present invention includes compositions and methods for enhancing an immune response with an adjuvant composition comprising: an anti-dendritic cell (DC)-specific antibody or fragment thereof conjugated to at least a portion of Toll-Like Receptor (TLR) agonist, more specifically a TLR7 ligand (TLR7L), and a pharmaceutically acceptable carrier, wherein the conjugate and agonist are each comprised in an amount such that, in combination with the other, are effective to produce the immune response in a human or animal subject in need of immunostimulation.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充